Lilly claims drug slows Alzheimer’s progression by 35 per cent in trial. However there are significant side effects that require our attention respecting the risk vs benefit and long-term outcomes.

Dr. Barry Dworkin

Medical Mythbusting Commentary for May 5, 2023

Lilly claims drug slows Alzheimer's progression by 35 per cent in trial. However there are significant side effects that require our attention respecting the risk vs benefit and long-term outcomes. Play Now | Play in Popup | Download

Source:
Lilly drug slows Alzheimer’s progression by 35 per cent in trial

Related posts:

  1. Do not hang your hat on an unapproved Alzheimer’s blood test.
  2. End of week wrap up: Not being able to stand on one legs means you die earlier?, Alzheimer an autoimmune disease?, and COVID vaccines saved millions of lives according to Lancet-published study.
  3. Discovery could explain why women are more likely to get Alzheimer’s
  4. Researchers report concerns about dementia following COVID-19 infection but the data is incomplete and much greater numbers of well-conducted studies need to be done to determine if there is a causal link.
Bitnami